Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lisinopril for Cognitive Impairment in SLE
NCT04486118Phase 2Active, not recruiting
- Sponsor
- Northwell Health
- Start
- Oct 2021
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lisinopril in systemic lupus erythematosus (SLE), sponsored by Northwell Health. Started Oct 2021; status: active, not recruiting.
02
Drugs
lisinopril
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT04486118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04486118.